Ortho Clinical Diagnostics Holdings plc

General Information
Business:

We are a pure-play in vitro diagnostics (“IVD”) business driven by our credo, “Because Every Test is A Life.” This guiding principle reflects the crucial role diagnostics play in global health and guides our priorities as an organization. As a leader in IVD, we impact approximately 800,000 patients every day. We are dedicated to improving outcomes for these patients and saving lives through providing innovative and reliable diagnostic testing solutions to the clinical laboratory and transfusion medicine communities. Our global infrastructure and commercial reach allow us to serve these markets with significant scale. We have an intense focus on the customer. We support our customers with high quality diagnostic instrumentation, a broad test portfolio and market leading service. Our products deliver consistently fast, accurate and reliable results that allow clinicians to make better-informed treatment decisions. Our business model generates significant recurring revenues and strong cash flow streams from ongoing sales of high margin consumables. In 2019, these consumables contributed more than 90% of our total revenue and approximately 93% of our core revenue. We maintain close connectivity with our customers through our global presence, with more than 4,500 employees, including approximately 2,200 commercial sales, service and marketing teammates. This global organization allows us to support our customers across more than 130 countries and territories.

We have been pioneering life-impacting advances in diagnostics for over 80 years, from our earliest work in blood typing, to our innovation in infectious diseases and our latest developments in laboratory solutions. In 2014, we were acquired by The Carlyle Group from Johnson & Johnson and became an independent organization, solely focused on delivering high quality IVD products and service to our diagnostic customer base. At the time of the separation, our business had global scale, a reputation for high quality products, a strong quality management system and a research and development team with extensive scientific expertise.

Industry: In vitro & in vivo diagnostic substances
Employees: 4500
Founded:
Contact Information
Address 1001 Route 202 Raritan, New Jersey 08869
Phone Number 908-218-8000
Web Address http://www.orthoclinicaldiagnostics.com/
View Prospectus: Ortho Clinical Diagnostics Holdings plc
Financial Information
Market Cap
Revenues $1723.3 mil (last 12 months)
Net Income $-172.6 mil (last 12 months)
IPO Profile
Symbol OCDx
Exchange NASDAQ
Shares (millions): 70.0
Price range $20.00 - $23.00
Est. $ Volume $1505.0 mil
Manager / Joint Managers J.P. Morgan/ BofA Securities/ Goldman Sachs/ Barclays/ Morgan Stanley
CO-Managers Citigroup/ Credit Suisse/ UBS Investment Bank/ Evercore ISI/ Piper Sandler/ ING/ Macquarie Capital/ Nomura/ TCG Capital Markets/ Drexel Hamilton/ H.C. Wainwright & Co./ Ramirez & Co./ Siebert Williams Shank
Expected To Trade: 1/28/2021
Day: Thursday
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change